DE69028101D1 - Melaninkonzentrierende hormone und dns die diese expremieren - Google Patents

Melaninkonzentrierende hormone und dns die diese expremieren

Info

Publication number
DE69028101D1
DE69028101D1 DE69028101T DE69028101T DE69028101D1 DE 69028101 D1 DE69028101 D1 DE 69028101D1 DE 69028101 T DE69028101 T DE 69028101T DE 69028101 T DE69028101 T DE 69028101T DE 69028101 D1 DE69028101 D1 DE 69028101D1
Authority
DE
Germany
Prior art keywords
mch
glu
peptides
ala
rat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028101T
Other languages
English (en)
Other versions
DE69028101T2 (de
Inventor
Joan Vaughan
Wolfgang Fischer
Jean Rivier
Jean-Louis Marie Nahon
Francoise Genevieve Presse
Wylie Vale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of DE69028101D1 publication Critical patent/DE69028101D1/de
Application granted granted Critical
Publication of DE69028101T2 publication Critical patent/DE69028101T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/854—Glands
DE69028101T 1989-03-22 1990-03-20 Melaninkonzentrierende hormone und dns die diese expremieren Expired - Fee Related DE69028101T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/326,984 US5049655A (en) 1989-03-22 1989-03-22 Melanin-concentrating hormones
PCT/US1990/001492 WO1990011295A1 (en) 1989-03-22 1990-03-20 Melanin-concentrating hormones and methods of treatment using same

Publications (2)

Publication Number Publication Date
DE69028101D1 true DE69028101D1 (de) 1996-09-19
DE69028101T2 DE69028101T2 (de) 1997-03-06

Family

ID=23274624

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028101T Expired - Fee Related DE69028101T2 (de) 1989-03-22 1990-03-20 Melaninkonzentrierende hormone und dns die diese expremieren

Country Status (8)

Country Link
US (3) US5049655A (de)
EP (1) EP0464105B1 (de)
JP (1) JP2944202B2 (de)
AT (1) ATE141288T1 (de)
CA (1) CA2046900C (de)
DE (1) DE69028101T2 (de)
DK (1) DK0464105T3 (de)
WO (1) WO1990011295A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849708A (en) * 1995-06-06 1998-12-15 Joslin Diabetes Center, Inc. Promotion of eating behavior
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
AU1802000A (en) * 1998-12-28 2000-07-24 Takeda Chemical Industries Ltd. Screening method
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US7220720B2 (en) * 2000-02-03 2007-05-22 Merk & Co., Inc. Melanin-concentrating hormone analogs
WO2001057070A1 (en) * 2000-02-03 2001-08-09 Merck & Co., Inc. Melanin-concentrating hormone analogs
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
GB0112343D0 (en) * 2001-05-21 2001-07-11 Norske Stats Oljeselskap Well treatment
US7314861B2 (en) * 2001-05-31 2008-01-01 Merck & Co., Inc. Melanin-concentrating hormone analogs
JP2004537581A (ja) * 2001-08-08 2004-12-16 メルク　エンド　カムパニー　インコーポレーテッド メラニン濃縮ホルモン拮抗物質
JP2005527491A (ja) * 2002-01-09 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド 選択的メラニン凝集ホルモンタイプ−１受容体アゴニスト
KR20030066187A (ko) * 2002-02-05 2003-08-09 나드리화장품주식회사 미백 화장료 조성물
KR20050103184A (ko) * 2002-11-06 2005-10-27 암젠 인코포레이션 융합된 헤테로사이클릭 화합물들
BRPI0512142B1 (pt) 2004-06-17 2018-01-23 Statoil Petroleum As Método para o tratamento de uma formação subterrânea, uso de um material, e, composição de tratamento de poço de hidrocarboneto
WO2005124099A1 (en) * 2004-06-17 2005-12-29 Statoil Asa Well treatment
BRPI0609877A2 (pt) * 2005-04-26 2010-05-11 Statoilhydro Asa processo de tratamento e construção de poços
KR100839194B1 (ko) 2006-12-14 2008-06-17 부경대학교 산학협력단 양식 넙치의 멜라닌농축호르몬
GB2450502B (en) * 2007-06-26 2012-03-07 Statoil Asa Microbial enhanced oil recovery
WO2009043523A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Cortistatin 17 and neuropeptide 1 for use as therapeutic agent
EP2187901B1 (de) * 2007-09-11 2012-08-08 Mondobiotech Laboratories AG Neuropeptid El und optional ACTH (7-38) zur Verwendung in der antiangiogenen Therapie

Also Published As

Publication number Publication date
JP2944202B2 (ja) 1999-08-30
EP0464105A4 (en) 1992-08-12
EP0464105B1 (de) 1996-08-14
US5449766A (en) 1995-09-12
EP0464105A1 (de) 1992-01-08
JPH04503812A (ja) 1992-07-09
US5530095A (en) 1996-06-25
CA2046900A1 (en) 1990-09-23
US5049655A (en) 1991-09-17
ATE141288T1 (de) 1996-08-15
CA2046900C (en) 2000-08-22
DK0464105T3 (da) 1997-01-06
WO1990011295A1 (en) 1990-10-04
DE69028101T2 (de) 1997-03-06

Similar Documents

Publication Publication Date Title
DE69028101D1 (de) Melaninkonzentrierende hormone und dns die diese expremieren
Prinz et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products
US7052684B2 (en) Methods of healing wounds and fibrotic disorders using IL-10
Goldstein et al. Thymosins: chemistry and biological properties in health and disease
AU676891B2 (en) Pharmaceutical containing the P40 subunit of interleukin 12
Lernhardt et al. T-cell hybridomas which produce B lymphocyte replication factors only
JP2010155859A (ja) 生物活性ケラチンタンパク質
DE60208692T2 (de) Interleukin -18 mutantenproteine, deren herstellung und verwendung
DE69332413D1 (de) Interleukin-2 analoge mit niedriger toxizität zur verwendung in der immuntherapie
JPH075481B2 (ja) 創傷の治癒
JPH03505870A (ja) 傷治癒
MX7701E (es) Procedimiento para preparar peptidos
CA2566776C (en) Method for ameliorating an inflammatory skin condition
ES8606400A1 (es) Procedimiento para preparar peptidos
ES2173856T3 (es) Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas.
ATE321856T1 (de) Humane rezeptortyrosinkinase
Bhartiya et al. Enhanced wound healing in animal models by interferon and an interferon inducer
TAKAOKA et al. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type)
JPH03500529A (ja) 増殖因子
Vaughan et al. DNA encoding NEI and NGE peptides
JP3160013B2 (ja) 新規ペプチド
JPH0551400A (ja) 短鎖コラーゲン
Hajri et al. Gastrin-releasing-peptide stimulates growth of a pancreatic acinar cell carcinoma in vitro and in vivo
Hajri et al. Expression of GRP receptors in normal and cancerous pancreatic cells
EP0556395A4 (en) Novel cytokine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee